Investibility 60%
Rate Now
$$$$$

About

Incorporated in 2009 and listed on the Singapore Stock Exchange, Biolidics Limited is a Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring.

Funding data

Round Stage Month / Year Amount Raised Lead Investors Other Investors
Round Stage Month / Year Amount Raised Lead Investors Other Investors
Sign up to see the funding data for Biolidics

Investors

Undisclosed.